| |
|
|
| Registros recuperados : 83 | |
| 7. |  | TEIXEIRA, O. R.; BATISTA, C. de S.; COLUSSI, R.; MARTINO, H. S. D.; VANIER, N. L.; BASSINELLO, P. Z. Impact of physicochemical properties on the digestibility of Brazilian whole and polished rice genotypes. Cereal Chemistry, v. 98, n. 5, p. 1066-1080, Sept./Oct. 2021.| Biblioteca(s): Embrapa Arroz e Feijão. |
|    |
| 9. | | VEREDIANO, T. A.; AGARWAL, N.; MARTINO, H. S. D.; KOLBA, N.; GRANCIERI, M.; PAES, M. C. D.; TAKO, E. Effect of black corn anthocyanin-rich extract (Zea mays L.) on cecal microbial populations in vivo (Gallus gallus). Nutrients, v. 14, n. 21, 4679, 2022.| Biblioteca(s): Embrapa Milho e Sorgo. |
|  |
| 10. | | THOMPSON, V. B. de M.; COSTA, N. N. B.; MARTINO, H. S. D.; PAES, M. C. D. The effect of micronized corn fiber on body weight, glycemia, and lipid metabolism in rats fed cafeteria diet. Food Science and Technology, v. 38, n. 3, p. 462-466, July/Sept. 2018.| Biblioteca(s): Embrapa Milho e Sorgo. |
| |
| 12. | | TONUCCI, L. B.; SANTOS, K. M. O. dos; OLIVEIRA, L. L. de; RIBEIRO, S. M. R.; MARTINO, H. S. D. Clinical application of probiotics in type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study. Clinical Nutrition, v. 36, n. 1, p. 85-92, 2017.| Biblioteca(s): Embrapa Agroindústria de Alimentos. |
| |
| 13. | | QUEIROZ, V. A. V.; MORAES, E. A.; MARTINO, H. S. D.; PAIVA, C. L.; MENEZES, C. B. de. Potencial do sorgo para uso na alimentação humana. Informe Agropecuário, Belo Horizonte, v. 35, n. 278, p. 7-12, jan./fev. 2014.| Biblioteca(s): Embrapa Milho e Sorgo. |
| |
| 16. | | TEIXEIRA, O. R.; CARVALHO, R. N.; COLUSSI, R.; MARTINO, H. S. D.; VANIER, N. L.; BASSINELLO, P. Z. Textura, amido resistente e digestibilidade In Vitro do amido de arroz de terras altas refrigerado e congelado após a cocção. In: SEMINÁRIO JOVENS TALENTOS, 15., 2021, Santo Antônio de Goiás. Resumos... Brasília, DF: Embrapa; Santo Antônio de Goiás: Embrapa Arroz e Feijão, 2021. p. 45. Evento online.| Biblioteca(s): Embrapa Arroz e Feijão. |
| |
| 17. | | GOMES, M. J. C.; MARTINO, H. S. D.; KOLBA, N.; CHENG, J.; AGARWAL, N.; ROCHA, M. de M.; TAKO, E. Zinc biofortified Cowpea (Vigna unguiculata L. Walp.) soluble extracts modulate assessed cecal bacterial pulations and gut morphology In Vivo (Gallus gallus). Frontiers in Bioscience - Landmark, v. 27, n. 5, 140, 2022.| Biblioteca(s): Embrapa Meio-Norte. |
| |
| 19. | | QUEIROZ, V. A. V.; MENEZES, C. B. de; BARROS, F. A. R. de; MARTINO, H. S. D. O sorgo na alimentação humana. In: PEREIRA FILHO, I. A.; RODRIGUES, J. A. S. (Ed.). Sorgo: o produtor pergunta, a Embrapa responde. Brasília, DF: Embrapa, 2015. cap. 15, p. 247-266. (Coleção 500 perguntas, 500 respostas).| Biblioteca(s): Embrapa Milho e Sorgo. |
| |
| Registros recuperados : 83 | |
|
|
|
 | Acesso ao texto completo restrito à biblioteca da Embrapa Agroindústria de Alimentos. Para informações adicionais entre em contato com ctaa.biblioteca@embrapa.br. |
Registro Completo
|
Biblioteca(s): |
Embrapa Agroindústria de Alimentos. |
|
Data corrente: |
02/12/2016 |
|
Data da última atualização: |
25/09/2017 |
|
Tipo da produção científica: |
Artigo em Periódico Indexado |
|
Circulação/Nível: |
A - 1 |
|
Autoria: |
TONUCCI, L. B.; SANTOS, K. M. O. dos; OLIVEIRA, L. L. de; RIBEIRO, S. M. R.; MARTINO, H. S. D. |
|
Afiliação: |
Livia Bordalo Tonucci, INTA; KARINA MARIA OLBRICH DOS SANTOS, CTAA; Leandro Licursi de Oliveira, UFV; Sonia Machado Rocha Ribeiro, UFV; Hercia Stampini Duarte Martino, UFV. |
|
Título: |
Clinical application of probiotics in type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study. |
|
Ano de publicação: |
2017 |
|
Fonte/Imprenta: |
Clinical Nutrition, v. 36, n. 1, p. 85-92, 2017. |
|
DOI: |
10.1016/j.clnu.2015.11.011. |
|
Idioma: |
Inglês |
|
Conteúdo: |
Background & aims: Type 2 diabetes has been associated with dysbiosis and one of the possible routes to restore a healthy gut microbiota is by the regular ingestion of probiotics. We aimed to investigate the effects of probiotics on glycemic control, lipid profile, inflammation, oxidative stress and short chain fatty acids in T2D. Methods: In a double-blind, randomized, placebo-controlled trial, 50 volunteers consumed daily 120 g/d of fermented milk for 6 wk. Participants were assigned into two groups: probiotic group, consuming fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp lactis BB-12 (109 colony-forming units/d, each) and control group, consuming conventional fermented milk. Anthropometric measurements, body composition, fasting blood and faecal samples were taken at baseline and after 6 wk. Results: 45 subjects out of 50 (90%) completed follow-up. After 6 wk, there was a significant decrease in fructosamine levels (9.91 mmol/L; p ¼ 0.04) and hemoglobin A1c tended to be lower (0.67%; p ¼ 0.06) in probiotic group. TNF-a and resistin were significantly reduced in probiotic and control groups (1.5 and 1.3 pg/mL, .1 and 2.8 ng/mL, respectively), while IL-10 was significantly reduced ( 0.65 pg/mL; p < 0.001) only in the control group. Fecal acetic acid was increased in both groups (0.58 and 0.59% in probiotic and control groups, respectively; p < 0.01). There was a significant difference between groups concerning mean changes of HbA1c (þ0.31 for control group vs 0.65 for probiotic group; p ¼ 0.02), total cholesterol (þ0.55 for control group vs 0.15 for probiotic group; p ¼ 0.04) and LDL-cholesterol (þ0.36 for control group vs 0.20 for probiotic group p ¼ 0.03). Conclusions: Probiotic consumption improved the glycemic control in T2D subjects, however, the intake of fermented milk seems to be involved with others metabolic changes, such as decrease in inflammatory cytokines (TNF-a and resistin) and increase in the acetic acid. MenosBackground & aims: Type 2 diabetes has been associated with dysbiosis and one of the possible routes to restore a healthy gut microbiota is by the regular ingestion of probiotics. We aimed to investigate the effects of probiotics on glycemic control, lipid profile, inflammation, oxidative stress and short chain fatty acids in T2D. Methods: In a double-blind, randomized, placebo-controlled trial, 50 volunteers consumed daily 120 g/d of fermented milk for 6 wk. Participants were assigned into two groups: probiotic group, consuming fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp lactis BB-12 (109 colony-forming units/d, each) and control group, consuming conventional fermented milk. Anthropometric measurements, body composition, fasting blood and faecal samples were taken at baseline and after 6 wk. Results: 45 subjects out of 50 (90%) completed follow-up. After 6 wk, there was a significant decrease in fructosamine levels (9.91 mmol/L; p ¼ 0.04) and hemoglobin A1c tended to be lower (0.67%; p ¼ 0.06) in probiotic group. TNF-a and resistin were significantly reduced in probiotic and control groups (1.5 and 1.3 pg/mL, .1 and 2.8 ng/mL, respectively), while IL-10 was significantly reduced ( 0.65 pg/mL; p < 0.001) only in the control group. Fecal acetic acid was increased in both groups (0.58 and 0.59% in probiotic and control groups, respectively; p < 0.01). There was a significant difference between groups concerning mean changes of Hb... Mostrar Tudo |
|
Palavras-Chave: |
Gut microbiota; Oxidative; Type 2 diabetes. |
|
Thesagro: |
Stress. |
|
Thesaurus NAL: |
inflammation; probiotics. |
|
Categoria do assunto: |
X Pesquisa, Tecnologia e Engenharia |
|
Marc: |
LEADER 02784naa a2200253 a 4500
001 2057801
005 2017-09-25
008 2017 bl uuuu u00u1 u #d
024 7 $a10.1016/j.clnu.2015.11.011.$2DOI
100 1 $aTONUCCI, L. B.
245 $aClinical application of probiotics in type 2 diabetes mellitus$ba randomized, double-blind, placebo-controlled study.$h[electronic resource]
260 $c2017
520 $aBackground & aims: Type 2 diabetes has been associated with dysbiosis and one of the possible routes to restore a healthy gut microbiota is by the regular ingestion of probiotics. We aimed to investigate the effects of probiotics on glycemic control, lipid profile, inflammation, oxidative stress and short chain fatty acids in T2D. Methods: In a double-blind, randomized, placebo-controlled trial, 50 volunteers consumed daily 120 g/d of fermented milk for 6 wk. Participants were assigned into two groups: probiotic group, consuming fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp lactis BB-12 (109 colony-forming units/d, each) and control group, consuming conventional fermented milk. Anthropometric measurements, body composition, fasting blood and faecal samples were taken at baseline and after 6 wk. Results: 45 subjects out of 50 (90%) completed follow-up. After 6 wk, there was a significant decrease in fructosamine levels (9.91 mmol/L; p ¼ 0.04) and hemoglobin A1c tended to be lower (0.67%; p ¼ 0.06) in probiotic group. TNF-a and resistin were significantly reduced in probiotic and control groups (1.5 and 1.3 pg/mL, .1 and 2.8 ng/mL, respectively), while IL-10 was significantly reduced ( 0.65 pg/mL; p < 0.001) only in the control group. Fecal acetic acid was increased in both groups (0.58 and 0.59% in probiotic and control groups, respectively; p < 0.01). There was a significant difference between groups concerning mean changes of HbA1c (þ0.31 for control group vs 0.65 for probiotic group; p ¼ 0.02), total cholesterol (þ0.55 for control group vs 0.15 for probiotic group; p ¼ 0.04) and LDL-cholesterol (þ0.36 for control group vs 0.20 for probiotic group p ¼ 0.03). Conclusions: Probiotic consumption improved the glycemic control in T2D subjects, however, the intake of fermented milk seems to be involved with others metabolic changes, such as decrease in inflammatory cytokines (TNF-a and resistin) and increase in the acetic acid.
650 $ainflammation
650 $aprobiotics
650 $aStress
653 $aGut microbiota
653 $aOxidative
653 $aType 2 diabetes
700 1 $aSANTOS, K. M. O. dos
700 1 $aOLIVEIRA, L. L. de
700 1 $aRIBEIRO, S. M. R.
700 1 $aMARTINO, H. S. D.
773 $tClinical Nutrition$gv. 36, n. 1, p. 85-92, 2017.
Download
Esconder MarcMostrar Marc Completo |
|
Registro original: |
Embrapa Agroindústria de Alimentos (CTAA) |
|
|
Biblioteca |
ID |
Origem |
Tipo/Formato |
Classificação |
Cutter |
Registro |
Volume |
Status |
Fechar
|
| Nenhum registro encontrado para a expressão de busca informada. |
|
|
